Hypertension, Vol 9, 513-517, Copyright © 1987 by American Heart Association
G Deray, RA Branch, WA Herzer, A Ohnishi and EK Jackson
The purpose of this study was to determine whether or not atrial
natriuretic factor can act directly on the juxtaglomerular cell in vivo to
inhibit hormone-induced renin release. To achieve this objective the
interaction between synthetic atrial natriuretic factor and two different
renin secretagogues was examined. To exclude any indirect effect of atrial
natriuretic factor on renin release due to changes in sodium delivery to
the macula densa, all studies were conducted in nonfiltering, canine
kidneys. In one series of studies renin release was stimulated by
intrarenal infusions of norepinephrine (3 micrograms/kg/min), and in a
second series of studies renin release was induced by intrarenal infusions
of prostacyclin (0.1 micrograms/kg/min). In both studies intrarenal
infusions of atrial natriuretic factor (0.3 micrograms/kg/min), which
provided supraphysiological levels of atrial natriuretic factor in the
renal arterial plasma, failed to attenuate hormone-induced renin release.
In contrast, adenosine, a well-known inhibitor of renin release, abolished
the renin release response to both hormones. These data indicate that, at
the dose used in this study, synthetic atrial natriuretic factor does not
act directly on the juxtaglomerular cell to attenuate hormone- induced
renin release. Further, these results imply that circulating endogenous
atrial natriuretic factor cannot directly attenuate juxtaglomerular cell
responsiveness.
ARTICLES
Effects of atrial natriuretic factor on hormone-induced renin release
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |